logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

All change for SEN?

4 September 2012

The Department for Education have published draft legislation on the revised framework to meet special educational needs for scrutiny by parliament. These proposals build on the Green Paper that was published last year and replace SEN statements with Education Health and Care Plans with the aim of providing holistic multi-agency support to meet a child’s needs from birth to 25.

Whilst it is very early days for the proposed reforms, and much of the proposed legislation looks familiar to that legislation which is currently in force, one aspect stands out – the division which existed in legislation between maintained schools and academies has disappeared. All are treated equally under the proposed legislation and therefore the arguments which arose in relation to Mossbourne Academy should be consigned to history once the proposals become law. This increased clarity over legal obligations can only be a good thing for parents, schools and local authorities alike.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up